Download Citation
Article Source:
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study
Montrucchio G,
Sales G,
Rumbolo F,
Palmesino F,
Fanelli V,
et al.
(2021)
Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
PLOS ONE 16(2): e0246771.
https://doi.org/10.1371/journal.pone.0246771